Dividend
-
-
-
-
-
-
-
pSivida To Present at the 30th Annual ROTH Conference
-
-
-
-
-
-
-
HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis Pain Study Data
-
-
-
-
-
-
-
Leading Retinal Specialists to Highlight pSivida’s Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences
-
-
-
-
-
-
-
pSivida’s Durasert™ Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
-
-
-
-
-
-
-
pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results
-
-
-
-
-
-
-
pSivida (PSDV) Appoints New Director
-
-
-
-
-
-
-
pSivida (PSDV) Says Results from First Phase 3 Trial of Medidur Presented at ASRS
-
377,674 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All